Bures J, Novak M, Radochova V, Kohoutova D, Prchal L, Martinek J
Pharmaceuticals (Basel). 2025; 17(12.
PMID: 39770430
PMC: 11678239.
DOI: 10.3390/ph17121588.
Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L
Signal Transduct Target Ther. 2024; 9(1):211.
PMID: 39174535
PMC: 11344989.
DOI: 10.1038/s41392-024-01911-3.
Lyu D, Gong M, Zhang Y, Lyu X
Syst Rev. 2022; 11(1):84.
PMID: 35501927
PMC: 9063050.
DOI: 10.1186/s13643-022-01964-x.
Takomthong P, Waiwut P, Yenjai C, Sombatsri A, Reubroycharoen P, Lei L
Pharmaceuticals (Basel). 2021; 14(9).
PMID: 34577588
PMC: 8470973.
DOI: 10.3390/ph14090888.
Vignon A, Salvador-Prince L, Lehmann S, Perrier V, Torrent J
Int J Mol Sci. 2021; 22(16).
PMID: 34445475
PMC: 8395727.
DOI: 10.3390/ijms22168769.
Alzheimer's disease: An evolving understanding of noradrenergic involvement and the promising future of electroceutical therapies.
Slater C, Wang Q
Clin Transl Med. 2021; 11(4):e397.
PMID: 33931975
PMC: 8087948.
DOI: 10.1002/ctm2.397.
History and progress of hypotheses and clinical trials for Alzheimer's disease.
Liu P, Xie Y, Meng X, Kang J
Signal Transduct Target Ther. 2019; 4:29.
PMID: 31637009
PMC: 6799833.
DOI: 10.1038/s41392-019-0063-8.
Experimental and Theoretical Approaches in the Study of Phenanthroline-Tetrahydroquinolines for Alzheimer's Disease.
Duarte Y, Gutierrez M, Alvarez R, Alzate-Morales J, Soto-Delgado J
ChemistryOpen. 2019; 8(5):627-636.
PMID: 31139552
PMC: 6528641.
DOI: 10.1002/open.201900073.
Cyclic peptidomimetic lead compounds to reduce neurotoxicity and associated oxidative stress in Alzheimer's disease.
Banerjee A, Yadav A
Int J Biomed Sci. 2013; 6(3):216-24.
PMID: 23675196
PMC: 3615259.
Metabolite profiling and biological activities of bioactive compounds produced by Chrysosporium lobatum strain BK-3 isolated from Kaziranga National Park, Assam, India.
Kumar C, Mongolla P, Sujitha P, Joseph J, Suresh Babu K, Suresh G
Springerplus. 2013; 2(1):122.
PMID: 23565355
PMC: 3616213.
DOI: 10.1186/2193-1801-2-122.
Synthesis, pharmacological assessment, and molecular modeling of acetylcholinesterase/butyrylcholinesterase inhibitors: effect against amyloid-β-induced neurotoxicity.
Silva D, Chioua M, Samadi A, Agostinho P, Garcao P, Lajarin-Cuesta R
ACS Chem Neurosci. 2013; 4(4):547-65.
PMID: 23379636
PMC: 3629749.
DOI: 10.1021/cn300178k.
2,3-dihydro-1H-cyclopenta[b]quinoline derivatives as acetylcholinesterase inhibitors-synthesis, radiolabeling and biodistribution.
Szymanski P, Laznickova A, Laznicek M, Bajda M, Malawska B, Markowicz M
Int J Mol Sci. 2012; 13(8):10067-10090.
PMID: 22949848
PMC: 3431846.
DOI: 10.3390/ijms130810067.
Tin (IV) chloride-promoted one-pot synthesis of novel tacrine analogues.
Hu H, Song L, Fang Q, Zheng J, Meng Z, Luo Y
Molecules. 2011; 16(2):1878-87.
PMID: 21343890
PMC: 6259742.
DOI: 10.3390/molecules16021878.
Investigation of the binding mode of (-)-meptazinol and bis-meptazinol derivatives on acetylcholinesterase using a molecular docking method.
Xie Q, Tang Y, Li W, Wang X, Qiu Z
J Mol Model. 2006; 12(4):390-7.
PMID: 16404617
DOI: 10.1007/s00894-005-0058-y.
Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease.
Small G, Erkinjuntti T, Kurz A, Lilienfeld S
CNS Drugs. 2003; 17(12):905-14.
PMID: 12962529
DOI: 10.2165/00023210-200317120-00004.
Identification of selective inhibitors of acetylcholinesterase from a combinatorial library of 2,5-piperazinediones.
Carbonell T, Masip I, Sanchez-Baeza F, Delgado M, Araya E, Llorens O
Mol Divers. 2002; 5(3):131-43.
PMID: 12197070
DOI: 10.1023/a:1016230600162.
Three-dimensional structures of Drosophila melanogaster acetylcholinesterase and of its complexes with two potent inhibitors.
Harel M, Kryger G, Rosenberry T, Mallender W, Lewis T, Fletcher R
Protein Sci. 2000; 9(6):1063-72.
PMID: 10892800
PMC: 2144661.
DOI: 10.1110/ps.9.6.1063.
A risk-benefit assessment of tacrine in the treatment of Alzheimer's disease.
Samuels S, Davis K
Drug Saf. 1997; 16(1):66-77.
PMID: 9010644
DOI: 10.2165/00002018-199716010-00005.
Dementia--an update.
Jagust W
West J Med. 1995; 163(5):473-4.
PMID: 8533415
PMC: 1303177.
